Ipamorelin
Selective GH Secretagogue
Pentapeptide growth hormone secretagogue that selectively stimulates GH release from the anterior pituitary without meaningfully elevating cortisol, prolactin, or ACTH. Studied for lean mass support, recovery, and sleep quality improvement.
Format
5mg / vial
Purity
>99.2%
Category
Performance
Storage
2–8 °C
Research Price
€79
5mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Research Protocol Bundles
GH Secretagogue Stack
CJC-1295 + Ipamorelin
The most widely studied growth-hormone peptide combination. CJC-1295 (no DAC) provides a clean GHRH pulse; Ipamorelin selectively stimulates GH release without cortisol or prolactin elevation.
Bundle total
€148
8% bundle saving
Documented Research Parameters
Research Dose
100–300 mcg
Frequency
1–3× daily (pulsatile)
Duration
8–16 weeks
Half-Life
~2 hours
Route(s)
Subcutaneous · Intramuscular
Solubility
Water
Reconstitution
2 ml bacteriostatic water per 5 mg vial
Key Research Findings
Does not significantly raise cortisol, prolactin, or ACTH — distinguishing it from first-generation GHRPs.
Administration proximate to natural GH release windows (late evening) enhances GH pulse amplitude in research models.
Half-life of ~2 hours limits systemic GH elevation — relevant for physiological vs supraphysiological research designs.
Administration Reference
Subcutaneous injection in the abdominal region. Pre-sleep administration is commonly timed to coincide with the natural GH pulse in research models. Rotating sites across abdomen and outer thigh between administrations. For pulse studies, administration 30–45 minutes before intended observation window.
Documented Combination Protocols
The most studied GHRH+GHRP combination — amplified GH pulse with high selectivity and physiological pulsatility.
Sustained GH elevation: DAC half-life combined with Ipamorelin's GH selectivity.
Gentle physiological GH axis research stack, preserving natural pulsatile patterns.
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.